Zimbabwe has declined a substantial US health deal worth $367m (£272m) spanning five years over Washington's insistence on confidential information.
This rejection was revealed after a internal memorandum dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "skewed".
An official representative has since explained that the US was seeking biological samples for research and profit while was unwilling to guarantee the benefits from future treatments.
"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for continued negotiations to reach a deal acceptable to both sides so the nation's critical HIV programme can continue.
Wider Implications
This rejection comes after a similar situation in neighbouring Kenya, where a high court suspended a similar health funding agreement following concerns were filed about the safety of citizens' medical information.
After returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had overseen assistance for the American government, but Trump claimed its spending was "wasteful" and his government was seeking government-to-government agreements to boost openness and accountability.
According to reports, Sixteen African countries have to date signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently on HIV treatment via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, without any corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"Effectively, our nation would provide the raw materials for medical research without any certainty that the end products would be accessible to our people should a new disease outbreak arise."
Sovereignty and Global Health
Mangwana further said that the American exit from the global health body and its push of one-on-one health agreements were disrupting systems already set up via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing system created to manage potential pandemics.
"This system is designed to guarantee that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage ongoing discussions with our American counterparts on how subsequent collaboration might be arranged in a way that respects the independence and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that talks need to persist considering a large portion of the nation's HIV programmes relied on international support.
"If technical issues arise, such as those involving information security or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it commented.
This impasse emphasises the continuing tensions between receiving much-needed international aid and safeguarding national sovereignty in an increasingly interconnected world.